Kenai Therapeutics is focused on revolutionizing neurodegenerative treatments using induced pluripotent stem cell (iPSC) technology to develop new cell replacement and gene-modified medicines for conditions like Parkinson's disease
Kenai Therapeutics is focused on revolutionizing neurodegenerative treatments using induced pluripotent stem cell (iPSC) technology to develop new cell replacement and gene-modified medicines for conditions like Parkinson's disease.